Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hank Kung is active.

Publication


Featured researches published by Hank Kung.


International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology | 1992

Radioiodinated 2-hydroxy-3-(4-iodophenyl)-1-(4-phenylpiperidinyl)propane: Potential radiotracer for mapping central cholinergic innervation in vivo

Simon M. N. Efange; Aloke K. Dutta; R. H. Michelson; Hank Kung; J.R. Thomas; J. Billings; R.J. Boudreau

Radioiodinated 2-hydroxy-3-(4-iodophenyl)-1-(4-phenylpiperidinyl)propane, 5 (4-HIPP), was synthesized and evaluated as a simple vesamicol-like radiotracer for mapping cholinergic pathways in the brain. Both enantiomers of 5 exhibit significant accumulation (approx. 2% of injected dose) and prolonged retention (t1/2 greater than 3 h) within the rat brain. The accumulation of radioiodinated 5 in the rat brain was reduced by up to 70% in the presence of vesamicol and its analogs. The levorotary isomer (-)-4-[123I]HIPP exhibits significant accumulation in the monkey brain, with a half-life of about 9 h. Radioiodinated 5 may therefore be a useful tool for studying cholinergic pathways in the brain.


European Journal of Nuclear Medicine and Molecular Imaging | 1994

Radioiodinated tracers for the evaluation of dopamine receptors in the neonatal rat brain after hypoxic-ischemic injury

Amal Zouakia; Sylvie Chalon; Hank Kung; Anne-Marie Dognon; Elie Saliba; Jean-Claude Besnard; Denis Guilloteau

In order to evaluate in vivo single-photon emission tomography (SPET) method of assessing cerebral function after hypoxic-ischemic injury in human neonates, we studied D1 and D2 dopamine receptors in a rat model. Seven-day-old rats underwent permanent unilateral common carotid ligation followed by exposure to 8% O2. Two weeks later, in brains with no visible loss of hemispheric volume, striatal dopaminergic receptors were studied, with [125I]TISCH and [1251]IBZM for the D1 and D2 dopamine receptors, respectively. Using [125I]TISCH, we observed no modifications of D1 receptors, but in contrast, ex vivo and in vitro autoradiographic experiments showed a 40% decrease in the striatal binding of [125I]IBZM on both the ipsilateral and the contralateral side to the carotid ligation. These alterations were detected with IBZM, a D2 dopamine receptor ligand usable for SPET imaging. Therefore, exploration of D2 receptors by SPET in human neonates suffering from perinatal hypoxia-ischemia may be valuable for the diagnosis and follow-up of cerebral function damages.


International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology | 1989

Synthesis, characterization and biodistribution of neutral and lipid-soluble 99mTc-PAT-HM and 99mTc-TMR for brain imaging.

Robert H. Mach; Hank Kung; Yu-Zhi Guo; Chi-Chou Yu; Vinayakam Subramanyam; Joseph C. Calabrese

Two new ligand systems for complexation with 99mTc were prepared. The two analogs of bisaminoethanethiol (BAT): N,N-bis(2-methyl-2-mercaptopropyl)-2,2-dimethylpropylenediamin e (PAT-HM) and N,N-bis[2-(2-ethyl-1-mercaptopropyl)] ethylenediamine (TMR), form neutral and lipid soluble complexes with 99mTc that readily penetrate the blood-brain barrier following i.v. injection into rats. Although the 99mTc chelates do not display the prolonged brain retention required for use in single photon emission computed tomographic imaging studies, the fact that each ligand forms a neutral and lipid-soluble complex of high chemical stability when coordinated with 99mTc warrants further investigation to increase the site- and organ-specificity of these agents.


Journal of Applied Toxicology | 1990

Acute toxicity and mutagenicity of the copper complex of pyruvaldehyde‐bis (N‐4‐methylthiosemicarbazone), Cu‐PTSM

Paul J. Kostyniak; Shaheen M. Nakeeb; Ellen M. Schopp; Alexander E. Maccubbin; Elizabeth K. John; Mark A. Green; Hank Kung


Society of Nuclear Medicine Annual Meeting Abstracts | 2008

Results of multi-center clinical trials comparing four 18F PET amyloid-imaging agents: Preclinical to clinical correlations

Daniel Skovronsky; R. Edward Coleman; Kirk A. Frey; Pradeep K. Garg; Masanori Ichise; Val J. Lowe; Mark Mintun; Dean Wong; Hank Kung


Journal of Mass Spectrometry | 1991

Mass spectral analysis diaminodithiol ligands used for the complexation of technetium‐99m

Robert H. Mach; Hank Kung


Society of Nuclear Medicine Annual Meeting Abstracts | 2011

Comparison of cell uptake of fluorine-18 labeled (2S,4R)-4-fluoro-glutamine (FGln) and (2S,4R)-4-fluoro-glutamic acid (FGlu)

Karl Ploessl; Limin Wang; Brian P. Lieberman; Wenchao Qu; Hank Kung


Archive | 2016

CCDC 1473972: Experimental Crystal Structure Determination

Jin Song; Zehui Wu; Beau Wangtrakuldee; Seok Rye Choi; Zhihao Zha; Karl Ploessl; Robert H. Mach; Hank Kung


Archive | 2016

UREA-BASED PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) INHIBITORS FOR IMAGING AND THERAPY

Hank Kung; Karl Ploessl; Seok Rye Choi; Zhihao Zha; Zehui Wu


Archive | 2016

CCDC 1473973: Experimental Crystal Structure Determination

Jin Song; Zehui Wu; Beau Wangtrakuldee; Seok Rye Choi; Zhihao Zha; Karl Ploessl; Robert H. Mach; Hank Kung

Collaboration


Dive into the Hank Kung's collaboration.

Top Co-Authors

Avatar

Karl Ploessl

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Robert H. Mach

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar

Seok Rye Choi

Seoul National University Hospital

View shared research outputs
Top Co-Authors

Avatar

Mei-Ping Kung

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar

Shunichi Oya

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar

Wenchao Qu

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar

Zhihao Zha

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar

Catherine Hou

University of Pennsylvania

View shared research outputs
Researchain Logo
Decentralizing Knowledge